Compare EXTR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXTR | ITGR |
|---|---|---|
| Founded | 1996 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.3B |
| IPO Year | 1999 | 2000 |
| Metric | EXTR | ITGR |
|---|---|---|
| Price | $22.04 | $125.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $21.20 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.7M | 861.5K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 616.67 | N/A |
| EPS | 0.31 | ★ 1.17 |
| Revenue | $1,283,593,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $13.33 | $1.69 |
| Revenue Next Year | $7.97 | $6.53 |
| P/E Ratio | ★ $71.00 | $107.10 |
| Revenue Growth | ★ 12.59 | 7.98 |
| 52 Week Low | $13.48 | $62.00 |
| 52 Week High | $33.73 | $126.14 |
| Indicator | EXTR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 79.41 |
| Support Level | $16.48 | $124.84 |
| Resistance Level | $25.20 | $126.14 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | 0.09 | -1.10 |
| Stochastic Oscillator | 7.85 | 84.85 |
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.